Juvelook vs Rejuran is a common comparison on Seoul clinic menus. Both are called skin boosters, but they contain different ingredients and are not interchangeable.
Juvelook combines poly-D,L-lactic acid (PDLLA) with hyaluronic acid (HA). Rejuran uses polynucleotide (PN)-based formulations. The right choice depends on your skin concern, treatment area and clinical assessment.
Rather than comparing brand popularity, examine the exact product, amount, practitioner, risks and total cost.
Quick Answer
Juvelook uses PDLLA plus HA; Rejuran is associated with PN-based injectables. Both are discussed for selected skin-quality concerns, but no strong head-to-head evidence proves one is universally better. Treatment choice should reflect the problem being treated and the specific product.
Compare Skin Boosters in Korea for the broader treatment options, then check Fornur's current enquiry availability.
Juvelook vs Rejuran: Key Differences
Ingredients: Juvelook - PDLLA + HA. Rejuran - PN-based formulations.
Comparison: Juvelook variants and delivery techniques differ; Rejuran products and formulations also vary. Confirm the exact commercial product in each case.
Best fit: Neither is a universal treatment for enlarged pores, pigmentation, acne scars, fine lines or hollow under-eyes.
Recovery: Redness, bruising, swelling, tenderness or visible injection marks can occur with either.
Cost and sessions: Both depend on product, quantity, treatment area, technique and provider. Avoid comparing package headlines alone.
Which Is Better for Pores, Fine Lines or Under-Eyes?
Pores and uneven texture can relate to oil production, scarring and ageing. Studies of PDLLA and PN products use different methods, so they cannot establish a single winner for every concern.
Under-eye darkness may reflect pigment, vessels, hollowness or thin skin. These causes need different assessment. Neither injectable should be presented as a standard under-eye solution.
For general glow or hydration, read the Korean Glass Skin Treatment guide. To clarify a skin concern before choosing a procedure, read Skin Analysis in Seoul.
For significant volume loss, consider whether Dermal Fillers in Korea is the more relevant treatment category.
What Does the Research Say?
Juvelook evidence
The official Juvelook product information confirms its PDLLA and HA ingredients. Different variants have distinct quantities and intended applications.
A preliminary PDLLA/HA study included 16 people and reported improvements in several skin measures. It received funding from Juvelook manufacturer VAIM, and the small sample limits certainty.
A 2026 microjet study followed 40 people who underwent five Juvelook sessions using a specific needle-free delivery system. Its findings do not establish results for every injection technique.
Rejuran and polynucleotide evidence
Rejuran's official website identifies its product families. PN and PDRN are related DNA-derived materials, but they should not automatically be treated as synonyms.
A 2025 PN systematic review included nine studies and 219 people. It reported promising results for some skin measures, but study quality was low to moderate.
A 2026 review assessed seven randomised PN/PDRN trials involving 183 participants across different applications. Category-level findings cannot prove a specific Rejuran product is superior to Juvelook.
Bottom line: Product ingredients, early evidence and clinical technique matter more than unverified online claims about a 'best' skin booster.
How Much Do Juvelook and Rejuran Cost in Korea?
There is no reliable nationwide price. A fair comparison requires the exact product and quantity, not just the name 'skin booster'.
Ask for an itemised quote showing:
Product name and variant, including manufacturer and amount.
Treatment area, delivery method and clinician.
Number of sessions, aftercare, follow-up and total charges.
A lower advertised price may cover a smaller amount or a different procedure. Avoid booking around a package price until the clinical plan is clear.
Compare Skin Boosters in Korea to review the treatment category. Contact Fornur to ask whether relevant consultation services are currently available.
Results, Downtime and Important Risks
Visible swelling and injection marks can distort an immediate result. Results and session spacing vary by formulation, technique, area and response; there is no universal schedule.
Common reactions include redness, tenderness, bruising and small bumps. Other complications can include infection or persistent nodules. For certain injectable fillers, rare unintended injection into a blood vessel can cause severe injury; ask about the specific proposed product's risks.
Seek urgent medical attention for severe or increasing pain, unusual skin blanching or discolouration, or any visual changes after facial injection.
Before treatment, check the product's authenticity, injector qualifications, emergency protocol and aftercare. Leave time for recovery before events or travel.
Planning Treatment in Seoul
Confirm whether you need follow-up appointments and whether your timeline allows them. The official Medical Korea directory lists registered providers treating international patients, but registration does not guarantee outcomes.
For more general treatment options, read Facial Treatments in Korea or explore Skin & Aesthetic treatments on Fornur.
Fornur Medical's consultation, matching and reservation services are preparing for launch. Check current availability before making travel or booking decisions.
Compare Options with Fornur
The right treatment is about product fit, not package popularity. Check ingredients, evidence, cost and safety with a qualified practitioner.
Explore Skin Boosters in Korea to understand treatment options. To check the current enquiry pathway, message Fornur about skin booster options.
Medical note: This guide is educational and not personalised medical advice. A named qualified medical reviewer must approve it before publication.
How This Guide Was Prepared
This guide is designed to help foreign residents and visitors understand common questions before making a decision. Details should always be confirmed directly with the relevant provider or an appropriately qualified professional.
- Author
- Mustafa
- Last reviewed
- November 22, 2026







